| Metric | Q4 2023 | Q3 2023 | Q4 2022 | QoQ Change | YoY Change |
|---|---|---|---|---|---|
| Revenue | $0 | — | — | — | — |
| Op. Income | -$431.4K | — | — | — | — |
| EPS (Diluted) | $0.11 | — | — | — | — |
| Free Cash Flow | -$264.4K | — | — | — | — |
| Item | Amount |
|---|---|
| REVENUE | $0 |
| Cost of Revenue | $0 |
| GROSS PROFIT | $0 |
| R&D Expenses | $0 |
| Selling & Marketing | $0 |
| General & Administrative | $0 |
| SG&A Expenses | $431.4K |
| Other Expenses | $0 |
| Operating Expenses | $431.4K |
| Cost & Expenses | $431.4K |
| OPERATING INCOME | -$431.4K |
| Interest Income | $7M |
| Interest Expense | $0 |
| Other Income/Expenses | $7M |
| INCOME BEFORE TAX | $7M |
| Income Tax Expense | $0 |
| Net Income from Continuing Ops | $7M |
| Net Income from Discontinued Ops | $0 |
| Other Adjustments | $0 |
| NET INCOME | $7M |
| Net Income Deductions | $0 |
| BOTTOM LINE NET INCOME | $7M |
| D&A | $0 |
| EBIT | $7M |
| EBITDA | $7M |
| EPS | $0 |
| EPS Diluted | $0 |
| Item | Amount |
|---|---|
| Net Income | $7M |
| Depreciation & Amortization | $0 |
| Stock-Based Compensation | $0 |
| Deferred Income Tax | $0 |
| Other Non-Cash Items | -$7M |
| Change in Working Capital | $167.0K |
| OPERATING CASH FLOW | -$264.4K |
| Capital Expenditure | $0 |
| Acquisitions (Net) | $0 |
| Purchases of Investments | $0 |
| Sales/Maturities of Investments | $0 |
| Other Investing Activities | $0 |
| NET CASH FROM INVESTING | $0 |
| Net Debt Issuance | $0 |
| Common Stock Repurchased | $0 |
| Common Dividends Paid | $0 |
| Other Financing Activities | $0 |
| NET CASH FROM FINANCING | -$85.0K |
| FREE CASH FLOW | -$264.4K |
| Net Change in Cash | -$349.4K |
| Item | Amount |
|---|---|
| Cash & Equivalents | $28M |
| Short-Term Investments | $0 |
| Net Receivables | $2M |
| Inventory | $0 |
| Other Current Assets | $1M |
| TOTAL CURRENT ASSETS | $31M |
| PP&E (Net) | $14M |
| Goodwill | $0 |
| Intangible Assets | $0 |
| Long-Term Investments | $0 |
| Tax Assets | $0 |
| Other Non-Current Assets | $2M |
| TOTAL NON-CURRENT ASSETS | $15M |
| TOTAL ASSETS | $46M |
| Account Payables | $2M |
| Short-Term Debt | $5M |
| Deferred Revenue | $1M |
| Other Current Liabilities | $5M |
| TOTAL CURRENT LIABILITIES | $15M |
| Long-Term Debt | $31M |
| Deferred Revenue NC | $0 |
| Deferred Tax Liabilities | $0 |
| Other Non-Current Liabilities | $183M |
| TOTAL NON-CURRENT LIABILITIES | $219M |
| TOTAL LIABILITIES | $233M |
| Common Stock | $0 |
| Additional Paid-In Capital | $12M |
| Retained Earnings | -$199M |
| Treasury Stock | $0 |
| Accum. Other Comp. Income | $0 |
| Other Equity | $0 |
| TOTAL STOCKHOLDERS' EQUITY | -$187M |
| Minority Interest | $0 |
| TOTAL EQUITY | -$187M |
| TOTAL LIABILITIES & EQUITY | $46M |
| Total Debt | $42M |
| Net Debt | $15M |
